<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03955094</url>
  </required_header>
  <id_info>
    <org_study_id>Auragain study</org_study_id>
    <nct_id>NCT03955094</nct_id>
  </id_info>
  <brief_title>Ambu® Auragain™ as a Conduit for Intubation in Paediatrics</brief_title>
  <official_title>Clinical Evaluation of Ambu® Auragain™ as a Conduit for Intubation in Paediatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted as a prospective observational study&#xD;
&#xD;
      This study will be done in any of the operating theatres of University Malaya Medical Centre&#xD;
&#xD;
      This study will involve paediatric cases ( ages 3-12 years )posted for elective operations&#xD;
      which require general anaesthesia with endotracheal intubation&#xD;
&#xD;
      Ambu Aura Gain will be used as a conduit for intubation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All eligible participants will be approached and recruited Informed consent will be obtained&#xD;
      Induction of general anesthesia will be as per usual standardized method Ambu® Auragain™ will&#xD;
      be inserted A paediatric flexible endoscope will be used to view the glottis and railroad an&#xD;
      endotracheal tube into the trachea Placement is confirmed and number of attempts and time&#xD;
      required for successful intubation is recorded Ambu® Auragain™ will be removed Number of&#xD;
      attempts and time taken for removal of Ambu® Auragain™ will be recorded Any complications&#xD;
      will be noted and recorded&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective observational study All eligible patients will be approached and recruited All patients will be assigned to a single group - the use of AMBU® AURAGAIN™ as a conduit for flexible scope intubation No comparison groups</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time taken to successful intubation via the Ambu® AuraGain™</measure>
    <time_frame>Time taken during procedure ( measured in seconds )</time_frame>
    <description>Successful intubation is confirmed via the equal air entry heard bilaterally on auscultation and a positive capnograph tracing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time taken required for removal of Ambu® AuraGain™ post intubation</measure>
    <time_frame>Time taken during procedure ( measured in seconds )</time_frame>
    <description>Successful removal of device is confirmed by equal air entry heard bilaterally on auscultation and a positive capnograph tracing</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time required for insertion of Ambu® AuraGain™</measure>
    <time_frame>Time taken during procedure ( measured in seconds )</time_frame>
    <description>Device insertion is limited to two attempts</description>
  </other_outcome>
  <other_outcome>
    <measure>Determine oropharyngeal leak pressure of Ambu® AuraGain™</measure>
    <time_frame>Immediately post procedure- insertion of Ambu® AuraGain™ ( measured in mmHg )</time_frame>
    <description>Standard oropharyngeal leak test performed</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Pediatric Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>AMBU® AURAGAIN™ device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assess feasibility of AMBU® AURAGAIN™ as an intubating device in paediatrics</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intubation via AMBU® AURAGAIN™</intervention_name>
    <description>Success rate of paediatric intubation through AMBU® AURAGAIN™</description>
    <arm_group_label>AMBU® AURAGAIN™ device</arm_group_label>
    <other_name>AMBU® AURAGAIN™</other_name>
    <other_name>Supraglottic device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Paediatric patients aged 3 - 12 years old&#xD;
&#xD;
          -  American Society of Anaesthesiologist (ASA) 1-2 patients&#xD;
&#xD;
          -  Patients must require standard endotracheal intubation for the procedure posted&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented history of difficult airway in previous general anaesthesia&#xD;
&#xD;
          -  Clinical features of difficult airway on physical examination&#xD;
&#xD;
          -  Syndromic patients, facial deformities, dental deformities, patients with facial&#xD;
             trauma&#xD;
&#xD;
          -  Patients with recent (less than 2 weeks) or ongoing upper respiratory tract infection&#xD;
&#xD;
          -  Patients with existing pulmonary diseases or any risk of bronchospasm&#xD;
&#xD;
          -  Patients with known gastric outlet obstruction, reflux disease, or any risk of&#xD;
             aspiration&#xD;
&#xD;
          -  Any other contraindication for device placement&#xD;
&#xD;
          -  Operations requiring specialised endotracheal tubes&#xD;
&#xD;
          -  Emergency operations or unanticipated difficult airway cases&#xD;
&#xD;
          -  Refusal of parental informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ismiarti S Ina, MAnaes(UM)</last_name>
    <role>Study Chair</role>
    <affiliation>University of Malaya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Malaya</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <reference>
    <citation>Sinha R, Chandralekha, Ray BR. Evaluation of air-Q™ intubating laryngeal airway as a conduit for tracheal intubation in infants--a pilot study. Paediatr Anaesth. 2012 Feb;22(2):156-60. doi: 10.1111/j.1460-9592.2011.03710.x.</citation>
    <PMID>21973052</PMID>
  </reference>
  <reference>
    <citation>Pandey RK, Subramanium RK, Darlong V, Lekha C, Garg R, Punj J, Rewari V, Bajpai M. Evaluation of glottic view through Air-Q Intubating Laryngeal Airway in the supine and lateral position and assessing it as a conduit for blind endotracheal intubation in children in the supine position. Paediatr Anaesth. 2015 Dec;25(12):1241-7. doi: 10.1111/pan.12746. Epub 2015 Sep 29.</citation>
    <PMID>26417722</PMID>
  </reference>
  <reference>
    <citation>Jagannathan N, Kozlowski RJ, Sohn LE, Langen KE, Roth AG, Mukherji II, Kho MF, Suresh S. A clinical evaluation of the intubating laryngeal airway as a conduit for tracheal intubation in children. Anesth Analg. 2011 Jan;112(1):176-82. doi: 10.1213/ANE.0b013e3181fe0408. Epub 2010 Nov 16.</citation>
    <PMID>21081777</PMID>
  </reference>
  <reference>
    <citation>Jagannathan N, Sohn LE, Sawardekar A, Gordon J, Shah RD, Mukherji II, Roth AG, Suresh S. A randomized trial comparing the Ambu ® Aura-i ™ with the air-Q ™ intubating laryngeal airway as conduits for tracheal intubation in children. Paediatr Anaesth. 2012 Dec;22(12):1197-204. doi: 10.1111/pan.12024. Epub 2012 Sep 13.</citation>
    <PMID>22971118</PMID>
  </reference>
  <reference>
    <citation>Jagannathan N, Sohn L, Ramsey M, Huang A, Sawardekar A, Sequera-Ramos L, Kromrey L, De Oliveira GS. A randomized comparison between the i-gel™ and the air-Q™ supraglottic airways when used by anesthesiology trainees as conduits for tracheal intubation in children. Can J Anaesth. 2015 Jun;62(6):587-94. doi: 10.1007/s12630-014-0304-9. Epub 2014 Dec 24.</citation>
    <PMID>25537736</PMID>
  </reference>
  <reference>
    <citation>Girgis KK, Youssef MM, ElZayyat NS. Comparison of the air-Q intubating laryngeal airway and the cobra perilaryngeal airway as conduits for fiber optic-guided intubation in pediatric patients. Saudi J Anaesth. 2014 Oct;8(4):470-6. doi: 10.4103/1658-354X.140841.</citation>
    <PMID>25422603</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>May 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>August 3, 2020</last_update_submitted>
  <last_update_submitted_qc>August 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Malaya</investigator_affiliation>
    <investigator_full_name>Dr Lim Su Sian</investigator_full_name>
    <investigator_title>Medical officer UD 48</investigator_title>
  </responsible_party>
  <keyword>AMBU® AURAGAIN™</keyword>
  <keyword>intubation in paediatrics</keyword>
  <keyword>flexible scope guided intubation</keyword>
  <keyword>success rate of intubation</keyword>
  <keyword>glottic view</keyword>
  <keyword>supraglottic airway intubation</keyword>
  <keyword>efficacy safety</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

